Understanding the BA.3.2 “Cicada” COVID-19 Variant: What You Need to Know
As of May 2026, public health officials continue to monitor the evolution of the SARS-CoV-2 virus. A new, heavily mutated variant known as BA.3.2—often referred to by the nickname “cicada”—has gained attention as it spreads across the United States. Understanding how this variant differs from previous strains is essential for maintaining personal and community health.
What Is the “Cicada” Variant?
The BA.3.2 variant, nicknamed “cicada” by Dr. T. Ryan Gregory, a professor of evolutionary biology at the University of Guelph, is a highly mutated strain of the virus that causes COVID-19. According to reports, the variant spent a significant period circulating at low levels before beginning to increase in prevalence in various countries, including the United States, late last year.
The primary concern among virologists, such as Dr. Andrew Pekosz of the Johns Hopkins Bloomberg School of Public Health, involves the variant’s spike protein. BA.3.2 possesses a significant number of genetic changes in this protein, which may allow it to evade immunity gained from previous infections or vaccinations. Because these mutations make the virus appear different to the immune system, public health agencies are closely tracking its trajectory.
Current Status and Monitoring
As of early April 2026, the Centers for Disease Control and Prevention (CDC) reported that BA.3.2 had been detected in more than half of U.S. States. In December 2025, the World Health Organization officially classified BA.3.2 as a “variant under monitoring.” This designation reflects the global effort to understand whether the variant’s genetic profile will lead to changes in transmissibility or disease severity.
Key Takeaways
- Genetic Changes: BA.3.2 is “hyper-mutated,” particularly in its spike protein, which may reduce the effectiveness of existing vaccine-induced or natural immunity.
- Widespread Presence: The variant has been identified in a majority of U.S. States and is being tracked globally.
- Ongoing Surveillance: Public health organizations continue to study the clinical impact of these mutations compared to other circulating strains.
Protecting Your Health
While new variants emerge as the virus continues to mutate, the fundamental pillars of COVID-19 prevention remain effective. Staying up to date with recommended vaccinations is the most reliable way to lower the risk of severe illness and hospitalization.
If you are experiencing symptoms or are concerned about potential exposure, consider the following steps:
- Testing: Utilize available testing resources to confirm an infection if you develop symptoms.
- Management: Consult with healthcare professionals regarding symptom management and potential treatment options, especially if you have underlying medical conditions that increase your risk.
- Stay Informed: Follow guidance from local health departments regarding current risk levels and recommended precautions in your specific area.
Frequently Asked Questions
Why is it called “cicada”?
The name was coined by Dr. T. Ryan Gregory due to the variant’s behavior; much like the insect, the virus remained largely undetected or “underground” for several years before re-emerging as a more prominent strain.
Do current vaccines work against BA.3.2?
Research suggests that the high number of mutations in the BA.3.2 spike protein may allow it to evade some of the protection provided by prior infections or vaccinations. However, staying up to date with vaccines remains the standard recommendation from health authorities to reduce the risk of severe complications.
Where can I find the latest updates?
For the most accurate and current information regarding COVID-19 protocols, testing, and treatment, always refer to official resources provided by the CDC and local public health agencies.
As the situation with the BA.3.2 variant evolves, we remain committed to providing evidence-based updates. Please consult your primary care physician for personalized medical advice regarding your health.